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A Novel Antiinflammatory Role for the Short-Chain
Fatty Acids in Human Labor
Chiara Voltolini, Sharon Battersby, Sophie L. Etherington, Felice Petraglia,
Jane E. Norman, and Henry N. Jabbour
Medical Research Council Human Reproductive Sciences Unit (C.V., S.B., H.N.J.) and Medical Research
Council Centre for Reproductive Health (J.E.N.), The Queen’s Medical Research Institute, Edinburgh
EH16 4TJ, United Kingdom; Division of Obstetrics and Gynaecology (C.V., F.P.), Department of
Pediatrics, Obstetrics, and Reproductive Medicine, University of Siena, Siena 53100, Italy; and Medical
Research Council Human Genetics Unit (S.L.E.), Western General Hospital, Edinburgh EH4 2XU, United
Kingdom
Human parturition is an inflammatory process that can be activated prematurely by pathological
stimuli. This study investigated the expression of G protein-coupled receptors GPR43 and GPR41
receptors in human uteroplacental tissues and the role of short-chain fatty acids (SCFA) in mod-
ulating inflammatory pathways in fetal membranes. Expression of GPR43 and GPR41 was inves-
tigated in uteroplacental tissues collected fromwomen delivering at term or preterm after ethical
approval and patient informed consent. The effect of SCFA on expression of inflammatory genes
was assessed in amnionexplants after culturewith amimetic of infection (lipopolysaccharide, LPS).
Sodiumpropionateeffect onLPS-inducedneutrophil chemotaxiswas evaluatedby transwell assay.
GPR43 and GPR41 mRNA expression was higher in myometrium and fetal membranes collected
from women after the onset of labor. GPR43 protein expression localized to immune cells and
vascular endothelium in themyometriumand epitheliumof fetalmembranes. Treatmentwith LPS
significantly increasedmRNA expression of GPR43 and inflammatory genes. Cotreatmentwith LPS
and sodium propionate decreased LPS-induced expression of inflammatory genes including IL-6,
IL-8, cyclooxygenase-2, IL-1, intercellular adhesion molecule-1, and platelet endothelial cell ad-
hesionmolecule-1 but not IL-1 or lymphocyte function-associated antigen-1. Sodium propionate
reduced LPS-induced neutrophil chemotaxis and protein secretion of the neutrophil chemoattrac-
tant IL-8. Finally, fetalmembraneexpressionofGPR43was significantlyhigher inwomendelivering
preterm with evidence of infection. GPR43-SCFA interactions may represent novel pathways that
regulate inflammatory processes involved in human labor. Suppression of inflammatory pathways
by SCFA may be therapeutically beneficial for pregnant women at risk of pathogen-induced pre-
term delivery. (Endocrinology 153: 395–403, 2012)
There is increasing evidence that human parturition isassociated with activation of inflammatory processes
in the uteroplacental unit (1, 2). These include a dramatic
influx of immune cells, increased expression and secretion
of inflammatory cytokines and chemokines (3, 4), and
tissue remodeling facilitated by production ofmatrixmet-
alloproteinases (5, 6). Additionally, in labor, peripheral
blood leukocytes have an increased chemotactic ability,
suggesting that inflammation is not just confined to
gestational tissues (7). Pathological stimulation of inflam-
matory events can lead to preterm labor (8), a major ob-
stetrical complication. Nevertheless, the mechanisms reg-
ulating the inflammatory processes of parturition and its
premature activation remain incompletely characterized.
In this study, we examined a putative role for short-
chain fatty acid (SCFA) signaling through the G protein-
coupled receptors (GPR43) and GPR41. These receptors
have been reported to bind to SCFAs such as acetate, pro-
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pionate and butyrate (9, 10). Acetate and propionate have
been shown to be the most specific and potent ligands for
GPR43, whereas propionate and butyrate can equally
bind GPR41 and GPR43 (9, 11). Although sharing the
same ligands, SCFA receptors show different tissue distri-
bution profiles. GPR43 is highly expressed in hematopoi-
etic tissue (spleen, bone marrow) and immune cells, in
particular neutrophils and monocytes, whereas GPR41 is
more widely expressed (12).
SCFAs are products of the anaerobic bacterial fermen-
tation of unabsorbed carbohydrates in the human intes-
tine, thus representing the fermentable dietary fiber. They
are subsequently transferred to the bloodstream after ab-
sorption by the intestinal mucosa. SCFA concentrations
increase with inflammatory disease, and high levels are
commonly found at sites of anaerobic bacterial infection
(13, 14). There is emerging evidence on the effects of
SCFAs in other tissues and organs (9, 15), including in-
volvement in immune processes, mostly as antiinflamma-
tory agents. They can regulate neutrophil function (16)
and modulate inflammatory cytokine expression, espe-
cially in the presence of inflammatory stimuli (12, 17, 18).
The highly selective expression ofGPR43on immune cells
and the parallel functional effects of SCFA on neutrophils
(9, 19) suggest that GPR43 receptor may specifically me-
diate SCFA inflammatory effects.
This study investigated the following: 1) GPR43 and
GPR41mRNA expression in human gestational tissues at
term and their regulation by lipopolysaccharide (LPS), 2)
the in vitro effect of SCFA on LPS-induced expression of
proinflammatory cytokines andadhesionmolecules in hu-
man amnion explants, and 3) GPR43 and GPR41mRNA
expression in gestational tissue from women affected by
spontaneous preterm labor (PTL) and preterm premature
rupture of membranes (pPROM) with or without chorio-
amnionitis (CA).
Materials and Methods
Patients and tissue collection
Uteroplacental tissues (myometrium, placenta, amnion,
chorion) were collected from a total of 22 women at term of
gestation (37 wk of gestation) delivering by cesarean sec-
tion, of whom 11 were nonlaboring (group A) and 11 were in
labor of spontaneous onset (group B) (Supplemental Table 1,
published on The Endocrine Society’s Journals Online web
site at http://endo.endojournals.org). From all term pregnant
patients, samples of myometrium, placenta, amnion, and cho-
rionwere collected and, fromnonlaboringwomen, a blood sam-
ple was taken for neutrophil chemotaxis assay (described in a
separate section). Nonlaboring women underwent elective ce-
sarean section before the onset of labor for indications such as
breech presentation and previous cesarean section, whereas la-
boring women underwent cesarean section for indications such
as cardiotocographic abnormalities and failure to progress in the
first stage of labor. All were healthy womenwith singleton preg-
nancy receiving perinatal care at the Simpson Centre for Repro-
ductiveHealth, The Royal Infirmary of Edinburgh, UK.Women
with medical complications such as hypertensive disorders, di-
abetes, pyrexia, and infections and those taking medication in-
cluding steroids and prostaglandins were excluded from the
study. All tissueswere collected and immediately either placed in
RNAlater (Applied Biosystems, Warrington, UK) and frozen at
80 C until assay or fixed in 4% neutral buffered formalin and
wax embedded for immunohistochemistry or placed in RPMI
1640 (Sigma, Poole, UK) (containing 2 mmol L-glutamine, 100
IU penicillin, and 100 g/ml streptomycin) and transported to
the laboratory for in vitro experiments.
A second cohort of samples (placenta and fetal membranes)
was collected from 26 women admitted to the Division of Ob-
stetrics and Gynecology, Policlinico Santa Maria alle Scotte, Si-
ena, Italy, and who delivered preterm (Supplemental Table 2).
The women had regular uterine contractions occurring at a fre-
quency of at least two to three every 10 min associated with
cervical changes between 23 and 34wk of gestation. All patients
received 12 mg dexamethasone administered im twice with an
interval of 12 h to induce fetal lung maturity, and all of them
deliveredwithin24hafterdexamethasone treatment.Allwomen
with pPROM received antibiotic therapy. Women delivering
preterm were divided into three groups according to the follow-
ing diagnoses: 1) PTL with intact membranes without histolog-
ical chorioamnionitis (n 9); 2) pPROM, defined as spontane-
ous rupture of themembraneswithin 37wk gestation at least 1 h
before the onset of contractions (n  10); and 3) pPROM with
histologic CAdiagnosed by the presence of inflammatory cells in
the chorionic plate and/or chorioamniotic membranes (n  7).
Women with cervical incompetence, uterine malformations,
polyhydramnios, multiple gestation, and fetal-maternal compli-
cations (thyroid disease, asthma, cardiovascular diseases, dia-
betes, hypertension, preeclampsia, abruptio placentae, fetal
growth retardation and fetal malformation) were excluded from
the study. The gestational age was assigned either on the basis of
the last menstrual period or ultrasound before 20 wk of gesta-
tion. Shortly after collection, tissues were placed in RNAlater
(QIAGEN, Milan, Italy) and frozen at 80 C until assay.
Ethical approvals were obtained from the respective local
research ethics committees in Edinburgh and Siena. Written in-
formed consent was obtained from all subjects before tissue
collection.
Amnion explants and treatment
Amnion from women in group A was transported in RPMI
1640, extensively washed in PBS, dissected into 8-mm discs of
tissue using a cork borer, and incubated overnight at 37 C in
serum-free RPMI 1640 medium. The explants were then placed
in 24-well plastic plates, with two discs of tissue per well. The
wells contained1mlRPMI1640as a vehicle, 100ng/mlLPS, 100
ng/ml LPS and 20 mmol sodium acetate, or 100 ng/ml LPS and
20mmol sodium propionate and incubated at 37 C for 8 or 24 h
(12, 20). Subsequently, supernatant and tissue were snap frozen
on dry ice and stored at 20 C and 80 C, respectively.
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Quantitative real-time PCR (qRT-PCR)
Total RNA was extracted from tissues using the QIAGEN
RNeasy minikit (QIAGEN Ltd., Crawley, West Sussex, UK),
according to the manufacturer’s instructions. RNA concentra-
tion (nanograms per microliter) for each sample was measured
usingaNanoDropspectrophotometerND-1000 (ThermoFisher
Scientific Inc., Wilmington, DE). cDNAwas synthesized using a
SuperScript VILO cDNA synthesis kit (no. 11754-250; Invitro-
gen Ltd., Paisley, UK). qRT-PCR was performed for SCFA re-
ceptors (GPR43, GPR41), proinflammatory cytokines [IL-1,
IL-1, IL-6, IL-8, cyclooxygenase (COX)-2] and adhesion mol-
ecules [intercellular adhesion molecule (ICAM)-1, lymphocyte
function-associated antigen-1 (LFA-1), platelet endothelial cell
adhesionmolecule (PECAM)-1] using Express qPCR Super-Mix
(no. 11785-200; Invitrogen). The sequences of primers and
probes for genes used for qRT-PCR are shown in Supplemental
Table 3. The qRT-PCR were carried out using an ABI 7900HT
Fast real-time PCR system machine (Applied Biosystems). Gene
expressionwas normalized for RNA loading using 18S rRNA as
internal standard and results are presented relative to a positive
RNA standard (cDNA obtained from endometrial adenocarci-
noma) included in all reactions.
Immunohistochemistry
Tissue sections (5 m) were dewaxed and rehydrated, and
antigen retrieval was performed by treating sections for 5 min in
apressure cooker in boiling 0.01Mcitrate buffer (pH6.0). Twenty-
four sections were analyzed from four women. Endogenous per-
oxidase activity was quenched with 10% (vol/vol) H2O2 in meth-
anol for 30 min at room temperature. Immunohistochemistry for
GPR43 was performed using an automated Visions Biosytems
bond immunohistochemistry system (Leica Microsystems Ltd.,
Milton Keynes, Bucks, UK). Sections were incubated for 120 min
using a rabbit antihuman polyclonal antibody to GPR43 (LS-
A6598;LifeSpanBiosciences Inc., Seattle,WA)at adilutionof 1:75
or omission of the primary antibody as a negative control. Sections
were subsequently treated for 15minwith polymer linked antirab-
bit peroxidase and counterstained in hematoxylin andmounted in
Pertex (Cellpath PLC, Powys, UK). Images were captured using an
OlympusProvisAX70microscope(OlympusU.K.Ltd.,Essex,UK)
equipped with an AxioCam HRc camera (Carl Zeiss AG, Jena,
Germany) and AxioVision 4.8 Imaging Software (Carl Zeiss).
Neutrophil chemotaxis assay
Neutrophilswere isolated fromperipheral bloodofwomen in
group A as previously described (21). Polymorphonuclear cells
of more than 95% neutrophil purity were used in this experi-
ment.Neutrophilswere resuspended in serum free assaymedium
(RPMI1640,1%penicillin-streptomycin,0.1%BSA)at cell con-
centration of 1  106 cells/ml. Neutrophil chemotaxis was an-
alyzed using transwell inserts (5 m pore size; Corning Costar,
Corning,NY). The potential chemoattractant, either i) 600l of
assay medium (negative control) or ii) 100 nmol N-formyl-me-
thionyl-leucyl-phenylalanine diluted in assay medium (positive
control) or iii) 600l ofmedium collected fromamnion explants
previously treated with either vehicle, 100 ng/ml LPS, 20 mmol
sodium propionate, or 100 ng/ml LPS  20 mmol sodium pro-
pionate for24h,wasadded to thebottomchamberof the24-well
plate. Transwell inserts were placed into the wells, and 1 105
neutrophils diluted in assay medium (final volume 100 l) were
added to the upper compartment. Plates were incubated at 37 C
in a 5% CO2 atmosphere for 1 h. After incubation, excess me-
dium was removed from the upper compartment and transwell
filters were placed inmethanol for 10min to fix cells; filters were
subsequently stained in Diff-Quick (Baxter Diagnostics, Inc.,
Deerfield, IL) for 20min and neutrophils countedmicroscopically
at 400 magnification (Axiovert 200M; Carl Zeiss). Data are ex-
pressed as mean  SE of neutrophils per high-power field (10 fields
counted) for duplicate filters from five independent experiments.
IL-8 ELISA
Secreted IL-8 was measured in supernatant collected from
amnion tissue explants (n  11 women) treated with vehicle or
LPS either aloneor in thepresenceof sodiumpropionate for 24h.
An in-house ELISAwas used, withmatched pairs of capture and
biotinylated labeled detection antibodies for IL-8 (R&D Sys-
tems, Minneapolis, MN). Plates were coated overnight at 4 C
with capture antibody (100 l/well) followed by 200 l/well of
dry coat/blocking solution for 1 h at room temperature. After
removing theblocking solution,plateswere storedat20Cuntil
analysis. Before use, the plates were washed twice inwash buffer
(0.05% Tween 20, 10 mmol/liter Tris, and 0.15 mol NaCl).
Recombinant IL-8 standard (R&D Systems) diluted in ELISA
buffer (using a concentration range of 1000 to 7.8 pg/ml) and
100 l of standard or supernatant sample were added per well.
FIG. 1. GPR43 and GPR41 mRNA expression in nonlaboring (NL) and
laboring (L) gestational tissues investigated by qRT-PCR. Both GPR43
(A) and GPR41 (B) genes showed significantly higher expression in
laboring than in nonlaboring myometrium (Myo), amnion and chorion.
No significant differences were found between laboring and
nonlaboring placenta (Pla) samples for both receptors. Data are
presented as means  SE; n  11 samples. *, P  0.05; **, P  0.01.
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Samples were analyzed in duplicate. Plates were incubated over-
night at 4 C and then washed before addition of anti-IL-8 de-
tection antibody (R&D Systems) at 60 ng/ml in ELISA buffer.
Plateswere subsequentlywashedbefore additionof streptavidin-
peroxidase (250 U/ml; Roche Molecular Biochemicals, Mann-
heim, Germany) at 1:2000 dilution in ELISA buffer (final con-
centration 0.125 U/ml) for 20–30 min at room temperature on
a rocker. Plates were again washed four times before addition of
tetramethylbenzidine substrate. Color change was monitored
and stopped using 2 N sulfuric acid. Plates were read on a plate
reader at 450 nm within 30 min of quenching. The minimum
detection limit of the assay was 15 pg/ml. The interassay and
intraassay coefficients of variance were 11 and 9.1% relative SD,
respectively.
Statistics
After assessing data distribution, statistical analysis was per-
formed using either (a) one-wayANOVAwhen comparing three
or more data sets or (b) a t test when comparing two data sets.
For one-way ANOVA, Friedman’s test or non parametric
ANOVA with Dunn’s posttest were used when data did not
assume a Gaussian distribution and ANOVA or repeated-measure
ANOVAwith Tukey’s posttest were applied when the normality
test was passed (GraphPad Prism version 5;GraphPad Software,
SanDiego,CA).All data are presented asmean SE. Significance
was assumed whenever P  0.05.
Results
GPR43 and GPR41 mRNA expression in laboring
and nonlaboring gestational tissues
GPR43andGPR41receptor expressionwasdetected in
all tissue samples collected from group A (n  11) and
group B (n  11) by qRT-PCR (Fig. 1, A and B). Expres-
sion of both receptors was significantly higher (P  0.01
and P  0.05 for GPR43 and GPR41, respectively) in
myometrium, amnion, and chorion but
not placenta collected from laboring
compared with nonlaboring women.
Expression of GPR43 mRNA was
highest in laboring amnion compared
with other gestational tissues.
GPR43 protein localization in
laboring and nonlaboring
gestational tissues
GPR43 protein was localized by im-
munohistochemistry (Fig. 2, A–F). In
the nonlaboring myometrium (Fig. 2A),
GPR43 protein localized to smooth
muscle cells and vascular endothelial
cells; in the laboring myometrium (Fig.
2B), the protein additionally localized
to the immune cells infiltrating the tis-
sue and inside thebloodvessels (1, 3, 6).
In theplacenta,GPR43wasdetectedon
the syncytiotrophoblast layer and in
immune cells in fetal blood vessels and
infiltrating the trophoblast (Fig. 2, C
and D, respectively). Finally, in amnio-
chorion, GPR43 was localized to am-
niotic epithelium, chorionic tropho-
blasts, and macrophages within the
chorionmesoderm (Fig. 2, E andF).Us-
ing current commercially available an-
tibody forGPR41,wehavebeenunable
to identify GPR41 staining; thus, local-
ization of GPR41 expression in utero-
placental tissues remains to be
elucidated.
FIG. 2. A–F, Localization of GPR43 protein in term nonlaboring and laboring gestational
tissues. Nonlaboring (A) and laboring (B) myometrium, nonlaboring (C) and laboring (D)
placenta, and nonlaboring (E) and laboring (F) fetal membranes show a positive staining for
GPR43 protein. Scale bar, 50 m. Negative controls are shown in inset (scale bar, 100 m in
the myometrium and placenta and 50 m in the fetal membranes). SM, Smooth muscles
cells; BV, blood vessel endothelium; IC, immune cells; SC, syncytiotrophoblast layer; FVB, fetal
blood vessels; AE, amniotic epithelium; CM, chorion mesoderm; CT, chorion trophoblast.
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In vitro GPR43 and GPR41 regulation by LPS in
human amnion explants
Because GPR43 mRNA levels were highest in the am-
nion, we subsequently investigated the effect of amimetic of
infection, LPS, on the expression of GPR43 and GPR41 in
amnion explant cultures. Termnonlaboring human amnion
explants (group A) were treated with either vehicle or 100
ng/ml LPS (Fig. 3). LPS treatment induced a significant in-
crease in GPR43 mRNA expression (measured by qRT-
PCR) at 8 h (47.4 10.3-fold above control, P 0.01) and
24h(47.212.8-foldabovecontrol,P0.01).LPSinduced
a modest increase in GPR41 mRNA expression at 24 h of
treatment (7.3 2.2-fold above control, P 0.05).
The SCFA sodium propionate reduces LPS-induced
expression of pro-inflammatory cytokines and
adhesion molecules
The mRNA expression of proinflammatory cytokines
(IL-6, IL-8, COX-2, IL-1, IL-1) and adhesion molecules
(ICAM-1, LFA-1, PECAM-1) in human amnion explants in
response to treatment with LPS alone or in the presence of
sodium acetate or sodium propionate for 8 and 24 h is pre-
sented in Fig. 4. In accordancewith previous in vitro studies,
treatmentof fetalmembraneswithLPS increased the expres-
sion of the proinflammatory cytokines (22, 23). Conversely,
we found that cotreatmentwith sodiumpropionate reduced
the LPS-induced expression of IL-6 at 8 and 24 h (P 0.05;
Fig. 4A), IL-8 and COX-2 at 24 h (P 0.05 and P 0.01,
respectively;Fig.4,BandC),andIL-1at24h(P0.01;Fig.
4D). LPS-induced expression of IL-1was not significantly
affected by cotreatment with sodium propionate (Fig. 4E),
whereas cotreatmentwith sodiumacetate had no significant
inhibitory effect on LPS-induced expression of any of the
studied pro-inflammatory genes (Fig. 4, A–E). LPS has been
shown previously to increase ICAM-1mRNA expression in
endothelial cells, nongestational tissues (24, 25), and syncy-
tiotrophoblast cells (26). However, the effect of LPS on
LFA-1 and PECAM-1 expression in gestational tissues has
not been elucidated and studies on nongestational tissues
have shown contrasting results (27–29). As expected, treat-
mentwithLPS increased expressionof ICAM-1mRNA.Co-
treating the amnion explants with LPS and the SCFA, either
sodium propionate or sodium acetate, significantly reduced
the LPS-induced ICAM-1 mRNA expression at 8 h after
treatment with sodium acetate (P 0.01) and at 8 and 24 h
after treatmentwith sodiumpropionate [(P0.01) Fig. 4F].
Treatment with LPS alone did not alter PECAM-1 mRNA
expression;however, cotreatmentwithLPSandsodiumpro-
pionate reduced expression of PECAM-1 at 8 and 24 h (P
0.01) compared with LPS treatment alone (Fig. 4G). LFA-1
mRNA expression was not altered by any of the treatments
(Fig. 4H).
Sodium propionate reduces LPS-induced
neutrophil chemotaxis in vitro
We subsequently determined whether the SCFA so-
dium propionate could affect the LPS effect on neutrophil
chemotaxis (30). Chemotaxis of neutrophils from preg-
nant women was significantly elevated after culture with
conditioned medium collected from amnion explants
treated with 100 ng/ml LPS compared with conditioned
medium collected from amnion explants treated with ve-
hicle control (P 0.001). Conditioned medium from ex-
plants cultured with 100 ng/ml LPS and 20 mM sodium
propionate reduced neutrophil chemotaxis compared
with conditioned medium from explants treated with LPS
alone (P  0.05) (Fig. 5A).
Sodium propionate reduces IL-8 protein secretion
in amnion explants treated with LPS
IL-8 is a chemokine known to induce chemotaxis of
neutrophils (31). Because we found that treatment with
sodium propionate reduces LPS-induced IL-8 mRNA ex-
pression and neutrophil chemotaxis, IL-8 protein levels
were assessed in medium collected from human amnion
explants treated with vehicle, LPS, or LPS and sodium
propionate for 24 h. IL-8 secretion was elevated in ex-
plants treated with LPS compared with vehicle (4.7 1.1
vs. 181.4  30.6 ng/ml for vehicle and LPS treatment,
respectively, P  0.001). Cotreatment with LPS and so-
diumpropionate significantly reduced IL-8 secretion com-
pared with explants treated with LPS alone (121.2 19.1
vs. 181.4 30.6 ng/ml, respectively, P 0.05) (Fig. 5B).
FIG. 3. GPR43 and GPR41 mRNA expression in term nonlaboring
amnion explants treated with either vehicle (veh) or 100 ng/ml LPS. LPS
induced a significant increase in GPR43 mRNA expression (white bars)
at 8 and 24 h compared with vehicle treatment (black bar) or
treatment with LPS for 4 h. GPR41 mRNA expression (gray bars)
increased significantly at 24 h LPS treatment. Data are presented as
means  SE; n  11 samples. *, P  0.05; **, P  0.01.
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In vivo GPR43 and GPR41 mRNA expressions in
preterm fetal membranes and placenta
To determine whether GPR41 and GPR43 may play a
role in the pathophysiology of parturition, expression of
GPR43 andGPR41mRNAwasmeasured by qRT-PCR in
fetal membranes and placenta collected from women de-
liveringpretermwith intactmembranes
(PTL), pPROM, or pPROMassociated
withCA (pPROMCA). Expressionof
GPR43 (Fig. 6A) was significantly
higher in fetal membranes collected
from women with pPROMCA com-
pared with fetal membranes collected
fromwomenwith PTL or pPROM.Ex-
pressionofGPR41 (Fig. 6C)was higher
in fetal membranes of women with
pPROMCA compared with fetal
membranes collected fromwomenwith
pPROM but not women with PTL.
There was no difference in the expres-
sion of GPR43 or GPR41 in placental
tissues collected from the three groups
of women (Fig. 6, B and D).
Discussion
We have shown, for the first time, ex-
pressionof the SCFA receptors (GPR43
and GPR41) in the human uterus and
related gestational tissues. We have
also demonstrated that LPS induces
GPR43 (and to a lesser extent GPR41)
mRNA expression in human amnion in
culture. The GRP41 and GPR43 recep-
tors appear functional, in that SCFA
(their natural ligands) inhibit LPS in-
duced pro-inflammatory cytokine ex-
pression and neutrophil chemotaxis in
amnion explants. Lastly, elevated ex-
pression in fetal membranes of women
with combined chorioamnionitis and
pPROMbut not pPROMalone or PTL
in the absence of pPROM/CA, suggests
a potential role for GPR41 and GPR43
in the pathology of infection induced
preterm labor.
The SCFA receptors (GPR43 and
GPR41) arewell known to be function-
ally involved in regulating the immune
system. Although these receptors can
be activated by the same ligands, their
expression patterns show different tis-
sue distribution. GPR43 expression is characterized by
high specificity for immune tissues and inflammatory cells
(9, 11): with expression mainly restricted to neutrophils,
monocytes, and (at lower levels) peripheral blood mono-
nuclear cells. In comparison with GPR43, the GPR41 re-
FIG. 4. mRNA expression of proinflammatory cytokines in human term nonlaboring amnion
explants after treatment with vehicle (black bars), 100 ng/ml LPS (white bars), 100 ng/ml LPS 20
mmol sodium acetate (light gray bars), or 100 ng/ml LPS 20 mmol sodium propionate (dark
gray bars). Sodium propionate reduced LPS-induced expression of IL-6 (A), IL-8 (B), COX-2 (C), and
IL-1 (D), but not IL-1 (E), in a time-dependent manner. Treatment with sodium acetate had no
effect on proinflammatory cytokine expression. LPS-induced ICAM-1 mRNA expression (F) was
significantly reduced by sodium propionate over the time courses, whereas PECAM-1 (G)
expression decreased after LPS sodium propionate treatment at 24 h, although not affected by
LPS treatment at any time course. LPS-induced LFA-1 (H) mRNA expression was not affected by
either LPS alone or LPS SCFA treatment. Data are presented as means SE; n 11 samples.
*, P 0.05; **, P 0.01; **, P 0.001. Data were log transformed to perform statistical analysis.
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ceptor ismorewidely expressed in several tissues including
adipose tissue, spleen, and lymph node as well as leuko-
cytes (11, 32).
Although we have shown gene expression for both re-
ceptors, availability of reagents meant that we were only
able to localize protein expression for GPR43 and not
GPR41. GPR43 protein was localized to multiple cellular
compartments including infiltrating im-
mune cells. We demonstrated func-
tional effects of GPR41 and GPR43
ligands (the SCFA): again, lack of avail-
ability of antagonists meant that we
were unable to investigate the differing
rolesof SCFAviaGPR41andGPR43 in
gestational tissues. Evidence attests
that GPR43 mediates antiinflamma-
tory activity. GPR43 is involved in neu-
trophil recruitment during intestinal in-
flammation (33), and GPR43-deficient
mice demonstrate exacerbated or unre-
solved inflammation in colitis, arthritis,
and asthma models, even after SCFA
supplementation (19). Both GPR43
andGPR41mediate additional, nonim-
mune effects, including adipogenesis
and inhibit lipolysis (GPR43) and stim-
ulation of leptin activity (GPR41) (34).
GPR43 knockout mice display loss of acetate mediated
reduction in plasma free fatty acid levels (34).
A role for inflammation in physiological and patholog-
ical parturition is well recognized (35). In fact, human
parturition at term and preterm are associatedwith a high
density of leukocytes and inflammatory cells in the myo-
metrium, cervix, and fetal membranes (3, 36). Labor is
also associated with increased pro-in-
flammatory cytokine production in
both gestational tissues (4, 36) and pe-
ripheral blood inflammatory cells (7).
Proinflammatory cytokines, in turn,
stimulate prostaglandin and matrix
metalloproteinase release at tissue level
that trigger the mechanisms of labor,
such as myometrial contractility, rup-
ture of themembranes, and cervical rip-
ening. PTL is widely considered to be
triggered by inflammatory processes,
either in the presence or absence of in-
fection. Focal infection and inflamma-
tion play a major role in the pathogen-
esis of CA, defined as inflammation of
the amniochorionic membranes of the
placenta in response to microbial inva-
sion (anaerobic, aerobic, and atypical
bacteria) or due to other pathological
processes (37). The definition of histo-
logical CA is based on microscopic ev-
idence of inflammation of the fetal
membranes characterized by infiltra-
tion of neutrophils and other immune
FIG. 5. A, Neutrophil chemotaxis measured by transwell assay in culture medium collected
from human amnion explants treated with vehicle (veh), 100 ng/ml LPS, or 100 ng/ml LPS and
20 mmol sodium propionate (Pro) for 24 h. Neutrophil chemotaxis was significantly increased
in medium collected from amnion explants treated with LPS compared with vehicle control
and was significantly reduced after culture with medium collected from amnion treated with
LPS and sodium propionate. Data are presented as percentage of cells that migrated in
response to conditioned medium compared with the number of cells that migrated in
response to the positive control [N-formyl-methionyl-leucyl-phenylalanine (fMLP)]. *, P 
0.05; ***, P  0.001. B, IL-8 protein levels in medium collected from human amnion explants
treated with either vehicle or LPS  sodium propionate for 24 h. IL-8 secretion was reduced
after treatment with LPS and sodium propionate compared with LPS treatment alone. Data
are presented as means  SE. *, P  0.05; ***, P  0.001.
FIG. 6. GPR43 and GPR41 mRNA expression measured by qRT-PCR in fetal membranes and
placenta samples collected from women delivering preterm: 1) PTL (n  9), 2) pPROM (n 
10), or 3) pPROM  CA (n  7). A, Fetal membranes GPR43 mRNA expression was
significantly higher in samples from women with pPROM  CA compared with women with
PTL and with pPROM. B, Placental GPR43 mRNA expression was similar among the three
groups. C, Expression of GPR41 mRNA in fetal membranes was significantly increased in
pPROM  CA samples compared with pPROM group. D, Placental GPR41 expression was
similar in the three groups. Data are presented as means  SE. *, P  0.05; **, P  0.01.
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cells, such asmacrophages and T cells. Regardless of the
infectious etiology, histological CA challenges the func-
tional integrity of fetal membranes with important
pathological consequences (38). Given the role of in-
flammation in labor, our data demonstrating elevated ex-
pressionofGPR41andGPR43 in gestational tissues during
both term labor and CA associated preterm labor suggest
that increased signaling through these receptors might
have functional effects during parturition, dampening
down a pro-inflammatory cytokine response and inhibit-
ing neutrophil chemotaxis.
Concerning intracellular pathways that drives SCFA
receptor up-regulation in response to inflammatory stim-
uli, little is known about transcriptional regulation of
GPR43 expression. One potential candidate could be the
nuclear factor-B pathway, which is potently activated by
LPS (39, 40). However, further research elucidating the
mechanisms governing expression of GPR43 would be
worthwhile. Evidence to date suggests that increased li-
gand/GPR41 orGPR43 receptor interactions occurring at
term or infection associated PTL is modulated at the re-
ceptor level: although SCFA concentrations are known to
increase with anaerobic infections (41), there are no
published reports on changes in circulating short chain
fatty acid concentrations in term or PTL. It is, however,
possible that these receptors can be activated by other
endogenous ligands not yet identified. Indeed, Milligan
et al. (42) have suggested that the low potency of SCFA
on GPR41 and GPR43 indicates they may be surrogate
rather than endogenous agonist. Synthetic ligands for
GPR43 are being developed (43). This raises the possi-
bility of pharmacological activation of this receptor in
vivo. Such activation could potentially be useful in in-
fection induced PTL to inhibit premature activation of
pro-inflammatory events of parturition. Such agents
could be of benefit, in combination with antimicrobial
therapy, to reduce maternal and fetal inflammation and
hence improve outcome in women with preterm labor
associated with intrauterine infection/inflammation.
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